http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27404034

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage i34
issn 0340-5354
1432-1459
issueIdentifier Suppl 1
pageRange i31-i34
publicationName Journal of Neurology
startingPage i31
bibliographicCitation Gerlach M, Foley P, Riederer P. The relevance of preclinical studies for the treatment of Parkinson's disease. J Neurol. 2003 Feb;250 Suppl 1():I31–4. doi: 10.1007/s00415-003-1106-y. PMID: 12761633.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c2487343abc02760ff4fe7de1446a88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a004534c26e96dfdc32c4e035370baf0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9075fcdf8d48bb66488a3c6cc72cff8
date 200302
identifier https://doi.org/10.1007/s00415-003-1106-y
https://pubmed.ncbi.nlm.nih.gov/12761633
isPartOf https://portal.issn.org/resource/ISSN/1432-1459
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5008
https://portal.issn.org/resource/ISSN/0340-5354
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title The relevance of preclinical studies for the treatment of Parkinson's disease
discusses http://id.nlm.nih.gov/mesh/M0019601
http://id.nlm.nih.gov/mesh/M0001494
http://id.nlm.nih.gov/mesh/M0014911
http://id.nlm.nih.gov/mesh/M0002366
http://id.nlm.nih.gov/mesh/M0182081
http://id.nlm.nih.gov/mesh/M0028008
http://id.nlm.nih.gov/mesh/M0012434
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4659569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26757
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_247ffeecb23de2fe2f08abecf230e799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128586172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128601362

Total number of triples: 37.